NET PROFIT (x1000 SEK)
EMPLOYEES
Amplexa Genetics A/S
Closing information (x1000 SEK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
0
|
0
|
0 |
| Earnings before taxes |
-6,024
|
-4,527
|
13,674 |
| Total assets |
22,297
|
18,383
|
25,254 |
| Current assets |
14,022
|
11,260
|
19,258 |
| Current liabilities |
2,958
|
1,743
|
5,929 |
| Equity capital |
3,540
|
-21,686
|
-16,789 |
| - share capital |
30,670
|
898
|
825 |
| Employees (average) |
7
|
7
|
7 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
15.9%
|
-118.0%
|
-66.5% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) | |||
| Current ratio |
474.0%
|
646.0%
|
324.8% |
| Return on equity (ROE) |
-170.2%
|
20.9%
|
-81.4% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.